StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck u.S. Product Returns Provision Rate (% of Gross U.S. Pharmaceutical Sales) (%)

Form 10-K Critical Accounting Estimates

Latest, FY2025
0.6%
Period ended Dec 31, 2025
Change on a year earlier
-0.2 pts
0.8% in FY2024
History
11 years
Since FY2015
Sources
8
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. Product Returns Provision Rate (% of Gross U.S. Pharmaceutical Sales) (%)Year on yearSource
FY2025Dec 31, 20250.6%-0.2 ptsForm 10-K (mrk-20251231.htm, filed 2026-02-24) ↗
FY2024Dec 31, 20240.8%-0.2 ptsForm 10-K (mrk-20251231.htm, filed 2026-02-24) ↗
FY2023Dec 31, 20231.0%-0.1 ptsForm 10-K (mrk-20251231.htm, filed 2026-02-24) ↗
FY2022Dec 31, 20221.1%+0.2 ptsForm 10-K (mrk-20231231.htm, filed 2024-02-26) ↗
FY2021Dec 31, 20210.9%+0.4 ptsForm 10-K (mrk-20231231.htm, filed 2024-02-26) ↗
FY2020Dec 31, 20200.5%-0.5 ptsForm 10-K (mrk-20221231.htm, filed 2023-02-24) ↗
FY2019Dec 31, 20191.0%-0.6 ptsForm 10-K (mrk-20211231.htm, filed 2022-02-25) ↗
FY2018Dec 31, 20181.6%-0.5 ptsForm 10-K (mrk-20201231.htm, filed 2021-02-25) ↗
FY2017Dec 31, 20172.1%+0.7 ptsForm 10-K (mrk1231201910k.htm, filed 2020-02-26) ↗
FY2016Dec 31, 20161.4%-0.1 ptsForm 10-K (mrk1231201810k.htm, filed 2019-02-27) ↗
FY2015Dec 31, 20151.5%–Form 10-K (mrk1231201710k.htm, filed 2018-02-27) ↗

Cite this data

StockData. (2026). Merck U.S. Product Returns Provision Rate (% of Gross U.S. Pharmaceutical Sales) (%), annual FY2015–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/gtn_us_returns_pct

See every metric in the Merck KPI table. Data updated Oct 26, 2026.